Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H10N4O2S2 |
Molecular Weight | 270.331 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)S1
InChI
InChIKey=VACCAVUAMIDAGB-UHFFFAOYSA-N
InChI=1S/C9H10N4O2S2/c1-6-11-12-9(16-6)13-17(14,15)8-4-2-7(10)3-5-8/h2-5H,10H2,1H3,(H,12,13)
Molecular Formula | C9H10N4O2S2 |
Molecular Weight | 270.331 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
62.88 μg/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/702289/ |
1 g single, oral dose: 1 g route of administration: Oral experiment type: SINGLE co-administered: |
SULFAMETHIZOLE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
144 μg × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/702289/ |
1 g single, oral dose: 1 g route of administration: Oral experiment type: SINGLE co-administered: |
SULFAMETHIZOLE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
1.4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/702289/ |
1 g single, oral dose: 1 g route of administration: Oral experiment type: SINGLE co-administered: |
SULFAMETHIZOLE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
Overview
CYP3A4 | CYP2C9 | CYP2D6 | hERG |
---|---|---|---|
OverviewOther
Other Inhibitor | Other Substrate | Other Inducer |
---|---|---|
Drug as perpetrator
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
yes | yes (co-administration study) Comment: can't access journal; 1.6-fold increase in tolbutamide AUC was predicted, which agreed well with reported increases in humans Sources: https://pubmed.ncbi.nlm.nih.gov/10725317/ |
PubMed
Title | Date | PubMed |
---|---|---|
Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone). | 1994 Feb |
|
Treatment failures after antibiotic therapy of uncomplicated urinary tract infections. A prescription database study. | 2002 Jun |
|
Class I integrons and SXT elements in El Tor strains isolated before and after 1992 Vibrio cholerae O139 outbreak, Calcutta, India. | 2003 Apr |
|
Clinical efficacy of trimethoprim/sulfadiazine and procaine penicillin G in a Streptococcus equi subsp. zooepidemicus infection model in ponies. | 2003 Aug |
|
Comparative immunohistochemistry and cellular distribution of farnesoic acid O-methyltransferase in the shrimp and the crayfish. | 2003 Oct |
|
[Prescriptions of a new antibiotic following treatment with sulfamethizole or pivmecillinam]. | 2003 Sep 22 |
|
Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua. | 2004 May |
|
Multiresidue determination of sulfonamides in a variety of biological matrices by supported liquid membrane with high pressure liquid chromatography-electrospray mass spectrometry detection. | 2004 Sep 8 |
|
Antibiotic resistance and antibacterial activity in heterotrophic bacteria of mineral water origin. | 2005 Jun 15 |
|
[Determination of residual sulfonamides in meat by high performance liquid chromatography with solid-phase extraction]. | 2005 Nov |
|
Antifungal and antibacterial resistance profiles between Cambodia and Kenyan children with human immunodeficiency virus infections receiving trimethoprim-sulfamethoxazole prophylaxis. | 2005 Nov |
|
Multiresidue determination of sulfonamides in edible catfish, shrimp and salmon tissues by high-performance liquid chromatography with postcolumn derivatization and fluorescence detection. | 2006 Aug 18 |
|
Oxidation of sulfonamides, macrolides, and carbadox with free chlorine and monochloramine. | 2006 Jul |
|
Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds. | 2006 Jul |
|
Absence of dihydropteroate synthase mutations in Pneumocystis jirovecii from Brazilian AIDS patients. | 2006 Jul-Aug |
|
Variability in antimicrobial resistance among Salmonella enterica strains from fattening pigs and sows. | 2006 Spring |
|
In-vitro antifungal activities of sulfa drugs against clinical isolates of Aspergillus and Cryptococcus species. | 2007 |
|
Optimizing therapy for Stenotrophomonas maltophilia. | 2007 Dec |
|
Simultaneous determination of 17 sulfonamides and the potentiators ormetoprim and trimethoprim in salmon muscle by liquid chromatography with tandem mass spectrometry detection. | 2007 Jan-Feb |
|
Analytical methods for multiresidue determination of sulfonamides and trimethoprim in meat and ground water samples by CE-MS and CE-MS/MS. | 2007 Nov |
|
Free-radical-induced oxidative and reductive degradation of sulfa drugs in water: absolute kinetics and efficiencies of hydroxyl radical and hydrated electron reactions. | 2007 Sep 20 |
|
[A case of Salmonella paratyphi A infection in Poland]. | 2008 |
|
Risk of miscarriage for pregnant users of pivmecillinam: a population-based case-control study. | 2008 Apr |
|
Simultaneous determination of sulfonamides, tetracyclines and tiamulin in swine wastewater by solid-phase extraction and liquid chromatography-mass spectrometry. | 2008 Aug 22 |
|
Toxicology profile of N-methyl-D-aspartate antagonists delivered by intrathecal infusion in the canine model. | 2008 May |
|
Gastric emptying for liquids and solids after distal gastrectomy with Billroth-I reconstruction. | 2008 May-Jun |
|
[What are we learning about Staphylococcus saprophyticus?]. | 2008 Oct |
|
Multiresidue determination of sulfonamides in chicken meat by polymer monolith microextraction and capillary zone electrophoresis with field-amplified sample stacking. | 2008 Sep 26 |
|
Electrocardiographic changes after shoulder arthroplasty. | 2008 Sep-Oct |
|
Analysis of antimicrobial resistance and plasmid profiles in Salmonella serovars associated with tropical seafood of India. | 2009 Jun |
|
A confirmatory method for the simultaneous extraction, separation, identification and quantification of Tetracycline, Sulphonamide, Trimethoprim and Dapsone residues in muscle by ultra-high-performance liquid chromatography-tandem mass spectrometry according to Commission Decision 2002/657/EC. | 2009 Nov 13 |
|
Antibiotic immunosensing: determination of sulfathiazole in water and honey. | 2010 Jun 15 |
|
Effects of short-term oral administration of trimethoprim-sulfamethoxazole on Schirmer II tear test results in clinically normal rabbits. | 2010 May 15 |
|
Prevalence of G6PD deficiency in a large cohort of HIV-infected patients. | 2010 Nov |
|
Putative-farnesoic acid O-methyltransferase (FAMeT) in medfly reproduction. | 2010 Oct |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18991182
Sulfamethizole is given orally at a dose of 1 gram twice daily for three days.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12604534
MIC values for Sulfamethizole were: 64 ug/ml (KMA-4845 and KMA-21476 E.coli strains), 128 ug/ml (KMA-26883 strain), 512 ug/ml (21804403-132 and UVI-203 strains), 1024 ug/ml (UVI-202 and 21398355-97 strains).
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:01:54 GMT 2023
by
admin
on
Fri Dec 15 15:01:54 GMT 2023
|
Record UNII |
25W8454H16
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 520.2280
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
||
|
WHO-VATC |
QD06BA04
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
||
|
WHO-ATC |
B05CA04
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
||
|
WHO-ATC |
S01AB01
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
||
|
WHO-VATC |
QB05CA04
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
||
|
WHO-ATC |
D06BA04
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
||
|
WHO-VATC |
QS01AB01
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
||
|
LIVERTOX |
910
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
||
|
NCI_THESAURUS |
C29739
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
||
|
WHO-VATC |
QJ01EQ02
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
||
|
WHO-ATC |
J01EB02
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1191
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
144-82-1
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
529
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
757327
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
D013419
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
SUB10710MIG
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
100000092325
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
1630009
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
9331
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
DB00576
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
205-641-1
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
4379
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
10179
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID5023615
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
SULFAMETHIZOLE
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
25W8454H16
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
m10318
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | Merck Index | ||
|
25W8454H16
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
5328
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
C47736
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY | |||
|
2512
Created by
admin on Fri Dec 15 15:01:54 GMT 2023 , Edited by admin on Fri Dec 15 15:01:54 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |